EUVIMEDEUVIMED entdecken
Kohortenstudie

Differential Impact of Chronic Kidney Disease Stages on the Survival Benefit of Percutaneous Coronary Intervention: A Large Real-world Cohort Study

Xiaozhao Lu iD, Jin Liu iD, Jingru Deng, Chenyang Wang iD, Yuqi Li, Jielan Wu, Ying Shi, Shiqun Chen iD, Ziyao Yuan, Ning Tan, Jiyan Chen, Yong Liu iD und 1 weitere

Angiology · 2025

DOI: 10.1177/00033197251324629 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Angiology, 2025. Verfasst von Xiaozhao Lu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Chi…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Renal Insufficiency, Chronic, Coronary Artery Disease. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Guangdong Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is prevalent among patients with coronary artery disease (CAD) and exacerbates myocardial ischemia. However, the survival benefit of percutaneous coronary intervention (PCI) across different stages of CKD remains controversial. CAD patients ( n = 17,418) with CKD (mean age, 69.5 ± 9.9 years; 70.9% male) were included in the Cardiorenal Improvement II cohort from 2007 to 2020. Patients were grouped by PCI or medical treatment and further categorized by stages 3a–5 CKD. Multivariable Cox regression was performed to investigate the associations of cardiovascular- and all-cause mortality with PCI and CKD stage, and to compare predictors of outcomes in patients stratified by advanced CKD. During a median follow-up of 4.2 years, 4605 (26.4%) participants died. Compared with medical treatment, PCI was not associated with improved survival benefit among patients with stage 3b–5 CKD (all P > .05). Among patients with advanced CKD, hypertension, hyperfibrinogenemia and moderate-severe malnutrition were more significantly associated with increased cardiovascular mortality with relatively high attributable risk. PCI was not associated with a survival advantage among patients with advanced CKD. Hypertension, hyperfibrinogenemia and malnutrition may contribute to poor prognosis in patients with advanced kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionRenal Insufficiency, ChronicCoronary Artery DiseaseHumansMaleFemaleAgedMiddle AgedRisk FactorsTreatment OutcomeRisk AssessmentSeverity of Illness Index

Stichwörter der Autor:innen

chronic kidney diseasecoronary artery diseasepercutaneous coronary interventionprognostic

Autor:innen und Institutionen

  • Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Department of Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Department of Cardiology, Zhongshan City People's Hospital, Zhongshan, China.
  • Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Province, China.
  • Global Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Science, Guangzhou, China.
  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Xiaozhao Lu, Jin Liu, Chenyang Wang, Shiqun Chen, Yong Liu

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Guangdong Medical Research Foundation
  • Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention
  • AstraZeneca Externally Sponsored Research Project

Zitieren

APA

Lu, X., Liu, J., Deng, J., Wang, C., Li, Y., Wu, J., Shi, Y., Chen, S., Yuan, Z., Tan, N., Chen, J., Liu, Y., & Gao, F. (2025). Differential Impact of Chronic Kidney Disease Stages on the Survival Benefit of Percutaneous Coronary Intervention: A Large Real-world Cohort Study. Angiology. https://doi.org/10.1177/00033197251324629

Vancouver

Lu X, Liu J, Deng J, Wang C, Li Y, Wu J, et al. Differential Impact of Chronic Kidney Disease Stages on the Survival Benefit of Percutaneous Coronary Intervention: A Large Real-world Cohort Study. Angiology. 2025. doi:10.1177/00033197251324629

BibTeX
@article{Lu2025,
  author = {Lu, Xiaozhao and Liu, Jin and Deng, Jingru and Wang, Chenyang and Li, Yuqi and Wu, Jielan and Shi, Ying and Chen, Shiqun and Yuan, Ziyao and Tan, Ning and Chen, Jiyan and Liu, Yong and Gao, Fei},
  title = {Differential Impact of Chronic Kidney Disease Stages on the Survival Benefit of Percutaneous Coronary Intervention: A Large Real-world Cohort Study},
  journal = {Angiology},
  year = {2025},
  doi = {10.1177/00033197251324629}
}
Kostenlos starten →